메뉴 건너뛰기




Volumn 46, Issue 1, 1996, Pages 238-240

Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

EID: 0029889376     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.1.238     Document Type: Article
Times cited : (57)

References (7)
  • 1
    • 0027472583 scopus 로고
    • Ischemic stroke in patients with atrial fibrillation: Effect of aspirin according to stroke mechanism
    • Miller VT, Rothrock JF, Pearce LA, et al. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Neurology 1993;43:32-36.
    • (1993) Neurology , vol.43 , pp. 32-36
    • Miller, V.T.1    Rothrock, J.F.2    Pearce, L.A.3
  • 2
    • 0000535219 scopus 로고
    • Warfarin compared to aspirin for prevention of arterial thromboembolism in atrial fibrillation: Design and patient characteristics of the Stroke Prevention in Atrial Fibrillation II Study
    • Stroke Prevention in Atrial Fibrillation Investigators. Warfarin compared to aspirin for prevention of arterial thromboembolism in atrial fibrillation: design and patient characteristics of the Stroke Prevention in Atrial Fibrillation II Study. Cerebrovasc Dis 1992;2:332-341.
    • (1992) Cerebrovasc Dis , vol.2 , pp. 332-341
  • 3
    • 2942696888 scopus 로고
    • Warfarin versus aspirin for the prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
    • Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for the prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-691.
    • (1994) Lancet , vol.343 , pp. 687-691
  • 4
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation
    • Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154:1449-1457.
    • (1994) Arch Intern Med , vol.154 , pp. 1449-1457
  • 5
    • 0027505093 scopus 로고
    • European Atrial Fibrillation Trial: Secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and recent transient ischemic attack or minor ischemic stroke
    • European Atrial Fibrillation Trial Study Group. European Atrial Fibrillation Trial: secondary prevention of vascular events in patients with nonrheumatic atrial fibrillation and recent transient ischemic attack or minor ischemic stroke. Lancet 1993;342:1255-1262.
    • (1993) Lancet , vol.342 , pp. 1255-1262
  • 6
    • 0025223161 scopus 로고
    • Atrial fibrillation - Risk marker for stroke
    • Chesebro JH, Fuster V, Halperin JL. Atrial fibrillation - risk marker for stroke. N Engl J Med 1990;323:1556-1558.
    • (1990) N Engl J Med , vol.323 , pp. 1556-1558
    • Chesebro, J.H.1    Fuster, V.2    Halperin, J.L.3
  • 7
    • 0029028805 scopus 로고
    • The Warfarin-Aspirin Symptomatic Intracranial Disease Study
    • in press
    • Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995 (in press).
    • (1995) Neurology
    • Chimowitz, M.I.1    Kokkinos, J.2    Strong, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.